PMI Preclinical was acquired by Covance, a subsidiary of LabCorp October 2018

October 31, 2018

Overview

Covance, the drug and medical device development subsidiary of LabCorp, acquired PMI Preclinical on October 29, 2018. PMI Preclinical is a US-based preclinical contract research organization specializing in medical device testing studies.

Significance

The acquisition expands Covance’s capabilities by leveraging PMI’s preclinical testing services to provide end-to-end solutions for medical device development.

Crosstree’s Role

Crosstree Capital Partners served as the exclusive financial advisor to PMI Preclinical.

PMI Preclinical was acquired by Covance, a subsidiary of LabCorp October 2018